美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
SANDOSTATIN	019667	001	NDA	OCTREOTIDE ACETATE	INJECTABLE;INJECTION	EQ 0.05MG BASE/ML	Yes	Yes	1988/10/21	1988/10/21	NOVARTIS	Prescription
SANDOSTATIN	019667	002	NDA	OCTREOTIDE ACETATE	INJECTABLE;INJECTION	EQ 0.1MG BASE/ML	Yes	Yes	1988/10/21	1988/10/21	NOVARTIS	Prescription
SANDOSTATIN	019667	003	NDA	OCTREOTIDE ACETATE	INJECTABLE;INJECTION	EQ 0.5MG BASE/ML	Yes	Yes	1988/10/21	1988/10/21	NOVARTIS	Prescription
SANDOSTATIN	019667	004	NDA	OCTREOTIDE ACETATE	INJECTABLE;INJECTION	EQ 0.2MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1988/10/21	1991/06/12	NOVARTIS	Discontinued
SANDOSTATIN	019667	005	NDA	OCTREOTIDE ACETATE	INJECTABLE;INJECTION	EQ 1MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	Yes	No	1988/10/21	1991/06/12	NOVARTIS	Discontinued
SANDOSTATIN LAR	021008	001	NDA	OCTREOTIDE ACETATE	INJECTABLE;INJECTION	EQ 10MG BASE/VIAL	Yes	No	1998/11/25	1998/11/25	NOVARTIS	Prescription
SANDOSTATIN LAR	021008	002	NDA	OCTREOTIDE ACETATE	INJECTABLE;INJECTION	EQ 20MG BASE/VIAL	Yes	No	1998/11/25	1998/11/25	NOVARTIS	Prescription
SANDOSTATIN LAR	021008	003	NDA	OCTREOTIDE ACETATE	INJECTABLE;INJECTION	EQ 30MG BASE/VIAL	Yes	Yes	1998/11/25	1998/11/25	NOVARTIS	Prescription